Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel + Cisplatin + 5-FU vs Cisplatin + 5-FU in Pediatric NPC
NCT00565448Phase 2Completed
- Sponsor
- Sanofi
- Start
- Nov 2007
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 2 trial of docetaxel in nasopharyngeal carcinoma (NPC), sponsored by Sanofi. Started Nov 2007; status: completed.
02
Drugs
docetaxel
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT00565448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00565448.